Background/Objectives: Data on associations between marine nÀ3 fatty acids and glucose metabolism are inconsistent. Therefore, we explored effects of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor (PPAR)-g2 gene on associations of fish intake and dietary and plasma eicosapentaenoic and docosahexaenoic acid with glucose metabolism. The design comprises of the cross-sectional analysis. Subjects/Methods: The Pro12Ala variant in the PPAR-g2 (PPARG) gene was genotyped in 571 non-diabetic relatives of subjects with type II diabetes. The dietary intake was measured by a 3-day food record, and the plasma cholesterol ester fatty acid composition was analysed with gas chromatography. Associations of dietary and plasma variables with insulin resistance and fasting and 2-h glucose and free fatty acid concentrations were analysed with multiple linear regression analysis. Results: In men, there was a significant interaction between PPARG polymorphism and plasma docosahexaenoic acid on fasting free fatty acid concentration (P ¼ 0.036), and genotype-stratified models showed an inverse association in Pro homozygotes only (P ¼ 0.028). In women, the proportion of plasma eicosapentaenoic acid was higher in Ala-allele carriers compared to Pro homozygotes (1.67 vs 1.44% respectively, P ¼ 0.006). A significant interaction between PPARG polymorphism and fish intake on 2-h glucose was found in women (P ¼ 0.021), and genotype-stratified models suggested an inverse association in Ala-allele carriers only (P ¼ 0.039). Conclusions: The findings suggest that PPARG polymorphism might affect the plasma proportion of eicosapentaenoic acid and modulate the associations of fish intake and marine nÀ3 fatty acids with glucose metabolism and fasting free fatty acids.
Introduction
The amount and type of dietary fat are assumed to contribute to the development of type II diabetes (TIID). Especially, long-chain nÀ3 polyunsaturated fatty acids have been found to be associated with enhanced glucose metabolism (Feskens et al., 1991; Adler et al., 1994; Feskens et al., 1995; Baur et al., 1998; Ekblond et al., 2000; Hu et al., 2001; Salmeró n et al., 2001; Thorsdottir et al., 2004) and to lower serum free fatty acid (FFA) concentrations (Gustafsson et al., 1998) , although there are also contradictory results (Salomaa et al., 1990; Borkman et al., 1993; Vessby et al., 1994a Vessby et al., , b, 2001 Pan et al., 1995; Marshall et al., 1997; Bjerregaard et al., 2000; Mori et al., 2000; Dewailly et al., 2001a, b; van Dam et al., 2002; Wang et al., 2003; Harding et al., 2004) . It is not known whether some of the discrepancies in previous results could be attributed to differences in the genetic background of the subjects.
The peroxisome proliferator-activated receptor (PPAR)-g is a transcription factor that controls the expression of genes involved in adipocyte differentiation, lipid storage, and insulin sensitization (Auwerx, 1999) . As PPAR-g can be activated by fatty acids (Xu et al., 1999) , we hypothesized that the effects of marine fatty acids on glucose metabolism could be partly mediated via PPAR-g, and therefore the common Pro12Ala polymorphism in the gene encoding for the PPAR-g2 (PPARG) might modify the associations of fatty acids with FFA and glucose levels and with insulin resistance. Earlier, the transcriptionally less active Ala-allele has been associated with enhanced insulin sensitivity (Ek et al., 2001) and antilipolytic effect of insulin (Stumvoll et al., 2001) , resulting in lower FFA concentrations (Stumvoll and Häring, 2002) , and with a reduced risk of TIID (Altshuler et al., 2000) . Against this background, we investigated whether the Pro12Ala polymorphism of the PPARG modified associations of fish intake or of dietary and plasma nÀ3 long-chain polyunsaturated fatty acids (eicosapentaenoic acid, EPA, 20:5nÀ3; docosahexaenoic acid, DHA, 22:6nÀ3) with FFA levels and measures of glucose metabolism in non-diabetic relatives of subjects with TIID.
A high level of unsaturation of skeletal muscle fatty acid composition has been related to enhanced glucose metabolism (Borkman et al., 1993; Pan et al., 1995; Baur et al., 1998) . Since EPA and DHA are formed from the 18-carbon a-linolenic acid (ALNA) through desaturation and carbonchain elongation, the activity of the enzymes involved in the conversion may affect the plasma levels of EPA and DHA. A genetic component has been suggested to contribute to the differences in the conversion (Pan et al., 1995) , and a recent study suggested a role for PPAR-g in the regulation of fatty acid desaturation (Risérus et al., 2005) . Therefore, we studied also whether plasma EPA and DHA proportions were affected by the Pro12Ala PPARG genotype.
Subjects and methods
In the Botnia Dietary Study (Ylönen et al., 2003) , 746 nondiabetic adult relatives of patients with TIID were invited to participate, and of them 603 (81%) completed the estimated 3-day dietary recording. After excluding 14 subjects with newly diagnosed diabetes and 18 subjects because of missing laboratory data, 259 men and 312 women were included in the analyses. Data on weight, height, waist and hip circumferences, glucose, insulin, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triacylglycerol, and FFA concentrations, length of education, physical activity and smoking were obtained with standardized methods (Ylönen et al., 2003) . Body mass index (BMI) was used as the measure of relative body weight, waist-to-hip ratio as the measure of central obesity and the homeostasis model assessment (HOMA) insulin resistance index as the measure of insulin resistance (Matthews et al., 1985) .
Serum fat was extracted from plasma with dichloromethane-methanol (Folch et al., 1957) , and cholesterol esters separated by thin layer chromatography from fat were transesterified with acidic methanol (5% H 2 SO 4 ) (Stoffel et al., 1959) . To determine the percentage fatty acid composition of the sample, a HRGC 412 Micromat gas chromatograph (HNU-Nordion Instruments, Helsinki, Finland) equipped with a 25-m-long NB-351 column (inner diameter 0.32 mm, phase layer 0.20 mm, HNU-Nordion Instruments), a split injection and a Sunicom Workstation (Helsinki, Finland) was used; helium was used as a carrier gas. Between-series variability was 1-3% for peaks over 4% and 5-10% for smaller peaks (for DHA 35%).
The PPARG Pro12Ala variant (rs1801282) was genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method and agarose gel electrophoresis using the primers 5 0 -GATAGAGACAAAATATCAGTG (forward) and 5 0 -GTATCAGTGAAGGAATCGCTTTCCG (reverse). PCR was performed in 20 ml of the volume containing 5 Â NH4 buffer, 10 mmol/l of each dNTP, 3 mmol/l of MgCl 2 , 0.5 U of Taq polymerase (Amersham Pharmacia Biotech, Piscataway, NY, USA), 1.5% of formamide, 4 pmol of each primer and 25 ng of genomic DNA. The cycling conditions were 961C for 3 min, 38 cycles of 961C for 30 s, 561C for 30 s and 721C for 60 s followed by final extension at 721C for 10 min. PCR products were followed by the digestion with BstU-1 at 601C for 2 h and separated on 6% agarose gel (SeaKem, Lonza, Basel, Switzerland) stained with ethidium bromide. The common allele 1 (Pro12) gave a 113-bp fragment and the variant allele 2 (Ala12), an 87 þ 25-bp fragments.
Statistical analyses were performed with software programs BMDP (version 7.1; BMDP Statistical Software Inc., Los Angeles, CA, USA) and SAS (version 8.2; SAS Institute Inc., Cary, NC, USA). Variables with skewed distributions were logarithmically transformed. When normality was not achieved, a non-parametric test was used or the variable was treated as categorical. The significance of difference in continuous variables between groups was tested by Student's unpaired t-test or Mann-Whitney U-test. Differences in categorical variables were analysed by w 2 test. A two-sided P-value o0.05 was considered statistically significant. Pearson's partial correlation coefficients were used to test the relationships between dietary vs plasma EPA and DHA after controlling for the effect of age. Multiple linear regression analysis was used to explore whether fish intake or dietary or plasma EPA and DHA (exposure variables) were related to the measures of glucose metabolism (HOMA insulin resistance index, fasting and 2-h plasma glucose) and fasting and 2-h serum FFA concentrations (outcome variables). The intakes of fatty acids included intake from supplements (by 17 subjects), and were presented as % of total fatty acids. Dietary and plasma fatty acids were included in the models as continuous variables. The intake of fish was dichotomized according to the sexspecific median. As the participants could be relatives, the analyses were performed with the PROC MIXED procedure (SAS/STAT software; SAS Institute), where the family connection was considered.
Potential interaction between the PPARG Pro12Ala polymorphism and the exposure variables was studied by models including as independent variables age, PPARG genotype, the exposure variable and the product term (genotype Â exposure variable), and thereafter by genotype-stratified analyses. The main potential confounding factors included in the further analyses were (sex), age, length of education, physical activity, BMI, waist-to-hip ratio, serum LDL and HDL cholesterol and serum triacylglycerols (all as continuous variables, except for sex). Additional models were adjusted for smoking and for the intake of energy, total fatty acids, linoleic acid, ALNA and alcohol. Alcohol intake was dichotomized to 0 g/day (median) vs more. Smoking was included in the models as two variables, the first variable coded as 0 for non-smokers and 1 for ex-smokers, and the second variable as 0 for non-smokers and 1 for smokers. Models analysing fish intake as the exposure variable were additionally adjusted for the intake of saturated fatty acids and dietary fibre. Dietary covariates were included in the analyses as energy-adjusted residual variables (Willett and Stampfer, 1986) .
Results

Characteristics and dietary data
Characteristics of the participants as well as their dietary intake and plasma levels of EPA and DHA are presented in Table 1 . The majority of the subjects had normal glucose tolerance. The proportion of plasma cholesterol ester DHA was higher in women compared to men. Based on this finding and the fact that fatty acid metabolism may be dependent on sex hormones (Lopes et al., 1991) , and the processes leading to impaired glucose metabolism may differ between men and women (North et al., 2007) , we provide mainly sex-specific analyses throughout the manuscript. The correlation coefficient between dietary and plasma EPA was 0.41 (Po0.0001) in men and 0.29 (Po0.0001) in women, and for DHA 0.30 (Po0.0001) and 0.17 (P ¼ 0.003) respectively.
General associations between fish variables and glucose metabolism Multiple linear regression analyses were first performed without taking into account the PPARG Pro12Ala polymorphism. Models were adjusted for age, length of education, physical activity, BMI, waist-to-hip ratio, serum LDL and HDL cholesterol and serum triacylglycerols. In men, a high proportion of plasma cholesterol ester DHA was associated with lower insulin resistance (regression coefficient (SEE) À0.13 (0.06), P ¼ 0.035). In women, high intakes of EPA (regression coefficient (SEE) À0.04 (0.01), P ¼ 0.006) and DHA (regression coefficient (SEE) À0.04 (0.01), P ¼ 0.015) were associated with lower 2-h serum FFA.
Differences in characteristics and plasma data between the PPARG Pro12Ala genotypes The frequency of the Ala12-allele was 12.5% in men and 13.8% in women, which is in keeping with the previous results. As there were only five male and eight female Ala homozygotes, Pro12Ala and Ala12Ala genotypes were pooled for further analyses. In men, Ala-allele carriers had higher waist-to-hip ratio (0.96 vs 0.95, P ¼ 0.043) but lower fasting serum FFA (413 vs 460 mmol/l, P ¼ 0.045) than Pro12Pro genotype carriers. In women, Ala-allele carriers had higher plasma EPA compared to Pro homozygotes (1.67 vs 1.44%, P ¼ 0.006), although the intakes of EPA (P ¼ 0.76) and ALNA (P ¼ 0.80) and the plasma level of ALNA (P ¼ 0.72) did not differ between the genotype groups.
Associations between fish variables and glucose metabolism with taking into account the PPARG Pro12Ala polymorphism In men we observed a significant interaction between the PPARG polymorphism and plasma DHA on the levels of fasting serum FFA (P ¼ 0.036) ( Table 2) . By the regression models stratified for genotype and adjusted for confounding factors, it was indicated that high plasma DHA, as well as high fish intake and dietary EPA and DHA (for which P for interaction with the polymorphism were 0.10-0.12), was associated with low fasting serum FFA only in male Pro12Pro genotype carriers, whereas no association was seen in Ala-allele carriers (Table 3) . The results did not appreciably change when the analyses were further adjusted for the dietary covariates and smoking.
A significant interaction between the PPARG polymorphism and the plasma EPA on insulin resistance was observed in men (P ¼ 0.040 (Table 2) ; in women P for interaction was 0.12). When men and women were analysed together in the stratified models, a high proportion of plasma EPA was associated with low insulin resistance in Ala-allele carriers (regression coefficient (SEE) À0.17 (0.08), P ¼ 0.038), while no association was seen in Pro12Pro genotype carriers (regression coefficient (SEE) 0.04 (0.04), P ¼ 0.28). These results remained virtually unchanged after the adjustment for smoking and the dietary covariates, including dietary EPA, or after including fasting or 2-h serum FFA into the model. In women, there was an interaction between the PPARG polymorphism and fish intake (P ¼ 0.020) as well as dietary DHA (P ¼ 0.041), and plasma EPA (P ¼ 0.016) and DHA (P ¼ 0.020) on the levels of postprandial 2-h plasma glucose (Table 4) . Regression analyses stratified for genotype suggested that the association of high fish intake with lower postprandial 2-h glucose concentration was restricted to Alaallele carriers and no such association was seen in Pro12Pro genotype carriers (Table 5) . Further adjustment for smoking and the dietary covariates, including the intake of saturated fatty acids and dietary fibre, did not notably change the result. Associations of dietary DHA and plasma EPA and DHA with the 2-h glucose concentration were not significant in the stratified models (Table 5) .
According to the present results, some of the interactions between the PPARG Pro12Ala polymorphism and fish variables on glucose metabolism might be sex-specific. Therefore, formal tests for interactions between sex, genotype and exposure variable on the outcomes were performed. These analyses yielded the following P-values for the third-order interaction terms (sex Â genotype Â exposure): fish intake on fasting serum FFA, P ¼ 0.095, and on 2-h plasma glucose, P ¼ 0.029; dietary EPA on fasting serum FFA, P ¼ 0.078; dietary DHA on fasting serum FFA, P ¼ 0.053, and on 2-h plasma glucose, P ¼ 0.13; plasma EPA on insulin resistance, P ¼ 0.74, and on 2-h plasma glucose, P ¼ 0.30; Exposure variables separately in the models. Models adjusted for age, length of education, physical activity, BMI, waist-to-hip ratio, serum LDL and HDL cholesterol and serum triacylglycerols. Table 4 Results of multiple linear regression analyses studying interaction between PPAR-g genotype and dietary and plasma exposure variables with respect to HOMA insulin resistance index, fasting and 2-h plasma glucose and fasting and 2-h serum FFA concentrations in female non-diabetic relatives of persons with type II diabetes plasma DHA on fasting serum FFA, P ¼ 0.038 and on 2-h plasma glucose, P ¼ 0.009. Thus, according to the present findings, interactions between the PPARG Pro12Ala polymorphism and plasma DHA on the fasting serum FFA and on the 2-h plasma glucose are sex-specific, as is that of fish intake on the 2-h plasma glucose.
Discussion
The key finding of the present study was that the Pro12Ala polymorphism of the PPARG gene can affect the associations of fish intake, EPA, and DHA with serum FFA and plasma glucose concentrations as well as with insulin resistance in high-risk individuals of TIID. Although the controversy in earlier data concerning marine fatty acids and glucose metabolism (Salomaa et al., 1990; Feskens et al., 1991 Feskens et al., , 1995 Borkman et al., 1993; Adler et al., 1994; Vessby et al., 1994a Vessby et al., , b, 2001 Pan et al., 1995; Marshall et al., 1997; Baur et al., 1998; Gustafsson et al., 1998; Bjerregaard et al., 2000; Ekblond et al., 2000; Mori et al., 2000; Hu et al., 2001; Salmeró n et al., 2001; Dewailly et al., 2001a, b; van Dam et al., 2002; Wang et al., 2003; Harding et al., 2004; Thorsdottir et al., 2004 ) may be partly explained by different doses and durations of supplementation in intervention studies, and by different background diets between the study populations, inclusion of subjects with different PPARG Pro12Ala genotypes could also influence the outcome of the study. That PPARG genotype may affect the associations of dietary fat composition with insulin concentrations (Luan et al., 2001) and serum triacylglycerol response to fish oil supplementation (Lindi et al., 2003) was suggested previously. In the present study, there were some indications of gender-specific effects. For example the association between fish intake and 2-h glucose levels was seen only in female Ala-allele carriers, but the relationship between the plasma EPA and an intermediate phenotype, that is, insulin resistance, was not restricted to women. This is in line with the results suggesting a better protection of the Ala-allele in women than in men (González Sánchez et al., 2002) . The correlations between dietary vs plasma EPA and DHA in the present study were comparable to the previous reports (Ma et al., 1995) , which support the relative validity of the dietary data.
Potential mechanisms by which marine nÀ3 fatty acids could beneficially affect glucose metabolism include lowering of circulating triacylglycerol and FFA concentrations (Pighin et al., 2003) , and of intramuscular lipids (Jucker et al., 1999) . The inverse associations of EPA and DHA intake with 2-h serum FFA in women of the present study are compatible with such a FFA-lowering effect of these fatty acids. As regards the metabolic effects of the Pro12Ala polymorphism of the PPARG gene, earlier results have shown that the Ala-allele is associated with enhanced antilipolytic effect of insulin (Stumvoll et al., 2001 ) and thereby lower FFA (Stumvoll and Häring, 2002) . In line with this, we found lower fasting FFA in carriers of the Ala-allele compared with the Pro/Pro genotype in men. However, the present study suggested further that the PPARG genotype may modulate the associations of marine fatty acids with FFA levels in men. High dietary and plasma marine fatty acids were associated with lower fasting FFA in male Pro homozygotes only. The metabolic alterations behind this finding are at the moment unknown but deserve attention in studies of the pathogenic mechanisms.
The mechanisms through which long-chain nÀ3 fatty acids may affect glucose metabolism include their incorporation into the phospholipids of plasma membranes, which increases the fluidity of the membranes and modulates the properties of membrane proteins mediating insulin action (Borkman et al., 1993; Liu et al., 1994; Mori et al., 1997) . In the present study, we observed higher plasma EPA in female Ala-allele carriers than in Pro/Pro females. As there was no clear difference in EPA or ALNA intake or plasma ALNA between the two genotype groups, the observed difference in plasma EPA could be due to a difference in the conversion of ALNA to EPA.
Earlier studies have shown that inter-individual variation in the conversion (Burdge et al., 2003) and in the ability to incorporate long-chain polyunsaturated fatty acids into muscle membranes is remarkable and may depend on sex, lifestyle factors and unknown genetic factors (Baur et al., 1998; Andersson et al., 2002; Pawlosky et al., 2003) . Furthermore, it has been observed that Pima Indians, who are at high risk for TIID, have a lower muscle phospholipid DHA level compared to a Caucasian population (Borkman et al., 1993; Pan et al., 1995) . This observation has urged the speculations that genetically determined differences in elongation and desaturation of fatty acids or their incorporation into membranes might contribute to the difference (Pan et al., 1995) . Our findings point to a higher conversion rate of ALNA to EPA in female Ala-allele carriers compared to Pro homozygotes, which could be compatible with such a genetic hypothesis. The resulting higher EPA could then enhance insulin action and contribute to the better protection of glucose metabolism in female Ala-allele carriers.
Based on the present findings, it could be hypothesized that the Pro12Ala polymorphism in the PPARG gene may modify the metabolic response to dietary marine fat. In men, the beneficial effect of fish intake on FFA levels may be restricted to Pro homozygotes, while the beneficial effects on the measures of glucose metabolism may be restricted to the carriers of the Ala-allele. In addition, the conversion of ALNA to EPA may be enhanced in female Ala-allele carriers. A higher conversion rate might contribute to better insulin action in this genotype group. These hypotheses deserve attention in future studies.
